| 영문 | VDRL(venereal disease research laboratory) | 한글 | 성병 연구실험실 |
|---|---|---|---|
| 설명 | 매독균의 reagin에 대한 항체. 매독의 선별검사로 사용되며 매독 치료에 대한 반응 여부와 치료효과 판정에도 사용된다. 매독외에도 전신성홍반성낭창, 류마티스관절염 등에서도 양성으로 나타날 수 있다. |
||
| HCG, hCG | Human Chorionic Gonadotropin; 사람융모성성선자극호르몬 1. Placental Glycoprotein Hormone &nbs... |
|---|---|
| ICU | infant care unit; immunologic contact urticaria; intensive care unit; intermediate care unit |
| OILD | occupational immunologic lung disease |
| ERF | Education and Research Foundation; external rotation in flexion; Eye Research Foundation |
| ICR | [distance between] iliac crests; Institute for Cancer Research; Institute for Cancer Research [mouse... |
| ARCI | Addiction Research Center Inventory |
|---|---|
| AHCPR | Agency for Health Care Policy and Research |
| AHRQ | Agency for Health Care Research and Quality |
| BMRC | British Medical Research Council |
| BMRR | Brookhaven Medical Research Reactor |
| horizontal survey | <epidemiology> A study of a community, perhaps stratified by age, sex, ethnicity etc., but at one point in time or over a short time interval. Although a snapshot, horizontal surveys of prevalence and intensity within different age classes of a community can nevertheless provide valuable information on the rate at which hosts acquire infection through time, provided that the host and parasite populations have remained approximately stable for a period of time (i.e. Stable endemicity). Same as cross-sectional study , converse of longitudinal study. (05 Dec 1998) |
|---|---|
| skeletal survey | A radiographic examination of all or selected parts of the skeleton, as for occult fractures, metastases, etc. (05 Mar 2000) |
| survey | 1. To inspect, or take a view of; to view with attention, as from a high place; to overlook; as, to stand on a hill, and survey the surrounding country. "Round he surveys and well might, where he stood, So high above." (Milton) 2. To view with a scrutinizing eye; to examine. "With such altered looks, . . . All pale and speechless, he surveyed me round." (Dryden) 3. To examine with reference to condition, situation, value, etc.; to examine and ascertain the state of; as, to survey a building in order to determine its value and exposure to loss by fire. 4. To determine the form, extent, position, etc, of, as a tract of land, a coast, harbor, or the like, by means of linear and angular measurments, and the application of the principles of geometry and trigonometry; as, to survey land or a coast. 5. To examine and ascertain, as the boundaries and royalties of a manor, the tenure of the tenants, and the rent and value of the same. Origin: OF. Surveoir, surveer; sur, sor, over, E. Sur + veoir, veeir, to see, F. Voir, L. Videre. See Sur-, and Vision, and cf. Supervise. Source: Websters Dictionary (01 Mar 1998) |
| survey line | A line scribed on an abutment tooth of a dental cast by means of a dental surveyor indicating the height of contour of the tooth according to a specific path of insertion, a line which serves as a guide in the proper location of various parts of a clasp assembly for a removable partial denture. Synonym: clasp guideline, Cummer's guideline. (05 Mar 2000) |
| field survey | The planned collection of data among noninstitutionalised persons in the general population. (05 Mar 2000) |
| adjuvants, immunologic | Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (freund's adjuvant, bcg, corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (12 Dec 1998) |
| receptors, immunologic | Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behaviour of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. (12 Dec 1998) |
| graft enhancement, immunologic | The induction of prolonged survival and growth of allografts of either tumours or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunised donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity. (12 Dec 1998) |
| monitoring, immunologic | Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumour antigen and other markers (often by radioimmunoassay), studies of cellular or humoral immunity in cancer aetiology, immunotherapy trials, etc. (12 Dec 1998) |
| contraception, immunologic | Contraceptive methods utilizing immunologic processes. (12 Dec 1998) |
| cytotoxicity, immunologic | The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitised T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. (12 Dec 1998) |
| cytotoxicity tests, immunologic | The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitised lymphocyte, an antibody, or complement. (12 Dec 1998) |
| suppressor factors, immunologic | Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility (I-j) and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory. (12 Dec 1998) |
| desensitization, immunologic | Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IgG, suppression of specific IgE, and an increase in suppressor T-cell activity. (12 Dec 1998) |
| dose-response relationship, immunologic | A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|